FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 20

Author

Admin 422 posts 0 comments

Whitepaper

How to Measure the Financial Impact of Physical Risks

Admin Jun 26, 2025
Physical risks resulting from climate change can be acute (driven by an event such as a flood or storm) or chronic…
Featured News

Finance Management: The Strategic Backbone of Organizational Success

Admin Jun 25, 2025
Finance is not just about managing money—it’s the strategic backbone that drives every business decision and…
Whitepaper

How Finance & Accounting Teams Can Enable Digital Transformation

Admin Jun 24, 2025
Financial inclusion has, for far too long, remained confined to corporate social responsibility for Indian banks.…
Featured News

SIPs Continue Growth Momentum as Mutual Fund Inflows Hit Record High in June 2025

Admin Jun 23, 2025
India’s mutual fund industry has reached a new milestone in June 2025, with Systematic Investment Plan (SIP)…
Featured News

Klarna Enters U.S. Mobile Market with 5G Plan, Signaling a Bold FinTech Expansion

Admin Jun 20, 2025
June 20, 2025 | New York, USA Swedish fintech giant Klarna—best known for its “buy now, pay later”…
Featured News

India’s Finance Minister Urges Fintechs to Expand into Rural MSME Sector

Admin Jun 19, 2025
India’s Finance Minister, Nirmala Sitharaman, recently called upon fintech companies to direct their innovation…
Whitepaper

Elevating client experiences for financial services with AI

Admin Jun 18, 2025
Discover how to transform client interactions and gain a competitive edge with AI-powered communication…
Featured News

Fintech 2025: IPO Success, AI Integration, and Global Expansion Reshape the…

Admin Jun 16, 2025
The fintech industry continues to experience a surge of innovation and investment in 2025, with several key…
Featured News

Global Fintech Market Booms as Digital Payments and AI Reshape Financial Services

Admin Jun 13, 2025
June 13, 2025 — The global fintech sector is experiencing a historic surge, driven by exponential growth in…
Whitepaper

Big Data and Ai for The Financial Sector: Challenges and Opportunities

Admin Jun 12, 2025
Artificial Intelligence (AI) is not a recently discovered field. Since the beginning of the computer science…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Everything You Should Know About Contactless Payments
    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future
    • 5 Approaches to Scaling Finance Accuracy with AI

    ARTICLE

    Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI™, at the SCALE Symposium
    2026-05-14T05:30:00Z
    PARIS, FRANCE, 14 May 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the presentation of the Phase II LANTIC trial for the first aesthetic glabellar lines indication with corabotase, a custom-designed molecule recognized as the first in...


    Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care
    2026-05-14T03:21:29Z
    SHANGHAI, May 14, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, and Shanghai Tenry Pharmaceutical Co., Ltd. (“Tenry...


    Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
    2026-05-14T02:00:00Z
    MELBOURNE, Australia , May 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including...


    Memopezil Under Investigation: Evaluating the Claims, Risks and Hidden Official Website Complaints about the Natural Donepezil Cocoa and Honey Protocol
    2026-05-14T01:09:43Z
    Bacopa Monnieri, Rhodiola Rosea, L-Theanine, and Panax Ginseng in Memopezil Supplement Facts, Refund Policy, Ingredients, and Cognitive Support Claims Explained


    JellyTide Claims Evaluated: The Gelatin Trick Recipe + Baking Soda Shot with Lemon for Weight Loss Using Jelly Tide Gummies
    2026-05-14T00:21:29Z
    JellyTide Scam or Legit? BHB Salts, Apple Cider Vinegar Gummies, Side Effects, Dosage, and 60-Day Guarantee Explained


    Hard Chews Gummies Claims Evaluated: Investigating the Salt Tonic Trick Recipe for Men
    2026-05-13T22:20:56Z
    Hard Chews Gummies Ingredients, Male Performance Support, L-Arginine, Tongkat Ali, Maca Root, 180-Day Guarantee, Pricing, and Subscribe and Save Researched


    Venus Concept Announces Senior Management Changes
    2026-05-13T21:25:00Z
    TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced changes to its senior leadership team.


    Management team’s 2025 market-based Options have vested
    2026-05-13T21:00:00Z
    Share price increase from $6 to $30 triggers full vesting


    Aptose Reports First Quarter 2026 Results 
    2026-05-13T21:00:00Z
    SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib...


    ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T20:55:00Z
    LIGHTHOUSE POINT, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (OTCQB: ZVSA), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of inflammatory and renal diseases...


    Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-13T20:35:00Z
    - Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046 - - FDA feedback on use...


    Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
    2026-05-13T20:30:00Z
    Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET


    Park Dental Partners Announces First Quarter 2026 Results
    2026-05-13T20:30:00Z
    MINNEAPOLIS, May 13, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its first-quarter...


    Combined General Meeting of June 3, 2026
    2026-05-13T20:30:00Z
    Châtillon, France, May 13, 2026


    EDAP | Focal One to Host Investor Day on June 1, 2026
    2026-05-13T20:30:00Z
    AUSTIN, Texas, May 13, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy-based therapies, today announced that it will host an Investor Day for...


    Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
    2026-05-13T20:25:58Z
    LEXINGTON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the...


    Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
    2026-05-13T20:07:25Z
    First clinical data from PRMT5/RAS(ON) combination trial to be presented in 2026


    Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
    2026-05-13T20:05:00Z
    CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human...


    SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
    2026-05-13T20:05:00Z
    Added 7 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue


    Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
    2026-05-13T20:05:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach...


    Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T20:05:00Z
    Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026


    Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
    2026-05-13T20:05:00Z
    JUPITER, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered,...


    Bionano Reports First Quarter 2026 Results and Provides a Business Update
    2026-05-13T20:05:00Z
    Conference call today, May 13, 2026, at 4:30 PM ET


    LogicMark, Inc. Announces Strong First Quarter 2026 Results
    2026-05-13T20:05:00Z
    Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows


    IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
    2026-05-13T20:05:00Z
    NASHVILLE, Tenn., May 13, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its first quarter results:


    Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-13T20:05:00Z
    100% insulin independence achieved in 10 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study


    Glass House Brands Reports First Quarter 2026 Financial Results
    2026-05-13T20:05:00Z
    LONG BEACH, Calif. and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF),...


    Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
    2026-05-13T20:05:00Z
    REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial...


    Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
    2026-05-13T20:05:00Z
    CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with...


    Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
    2026-05-13T20:05:00Z
    MIAMI, May 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today reported financial...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.